NIH-funded research R01 grant

How EphA2 controls artery plaque behavior and stability

Official title: EphA2 regulation of atherosclerotic smooth muscle phenotype

Funded at Louisiana State Univ Hsc Shreveport · NIH-11337620 · Data updated 2026-11-12

A study in people at risk for artery disease looks at how a specific cell signal (EphA2) influences inflammation and plaque stability in arteries.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLouisiana State Univ Hsc Shreveport
NIH-funded
Lab location1 site (Shreveport, United States)
Project startJuly 1, 2024
Project endMay 31, 2028
Funding year2026
Award (this year)$704,669
NIH project number5R01HL173972-03
Project IDNIH-11337620 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with atherosclerotic cardiovascular disease or at risk for plaque instability may be relevant for future translation of these findings.

Less likely to help

The study itself is preclinical and does not involve direct treatment or testing in patients at this stage.

What this research studies

This project explores how the EphA2 signaling pathway affects the behavior of smooth muscle cells and immune cells within atherosclerotic plaques. Researchers will examine how EphA2 interactions influence inflammatory gene expression, cell proliferation, and the fibrous cap that helps stabilize plaques. The work combines laboratory analyses with models that mimic human artery disease to understand how different EphA2 signaling routes may either promote instability or strengthen plaque structure. Results could point to new ways to predict plaque rupture risk or guide future therapies aimed at stabilizing diseased arteries.

Why it matters

Potential benefit: If successful, the findings could lead to new targets to prevent plaque instability and reduce heart attack risk.

How similar studies have gone: Prior research has linked EphA2 signaling to cell proliferation and inflammation, but the exact role in human plaque stability is being clarified in this project.

Where this research is happening

  • Louisiana State Univ Hsc Shreveport
    Shreveport, United States
    Active

Researchers

  • Principal investigator: Orr, Anthony Wayne — Louisiana State Univ Hsc Shreveport
  • Study coordinator: Orr, Anthony Wayne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.